Adagio Medical Holdings (ADGM) Debt Ratio (2023 - 2024)

Adagio Medical Holdings (ADGM) reported Debt Ratio of 0.33 for Q4 2024, up 23.21% on a YoY basis from 0.27 in Q1 2024, and up 158.69% sequentially from 0.13 in Q3 2024.

Adagio Medical Holdings (ADGM) Debt Ratio (2023 - 2024) Analysis & Trends

Adagio Medical Holdings (ADGM) has 2 years of Debt Ratio data on file, last reported at 0.33 in Q4 2024.

  • For the quarter ending Q4 2024, Debt Ratio rose 23.21% year-over-year to 0.33; the trailing twelve-month figure through Dec 2024 stood at 0.33 (up 23.21% YoY), and the FY2024 full-year result was 0.33, up 23.21% from the prior year.
  • Debt Ratio improved to 0.33 in Q4 2024, from 0.13 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.33 in Q4 2024 to a low of 0.13 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 0.31
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 0.32
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 0.30
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 0.04
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 0.30
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 0.27
9 Smith & Nephew 25.80 Bn 25.22 Bn - 0.30
10 Adagio Medical Holdings 21.49 Mn 21.49 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 0.33
Sep 30, 2024 0.13
Dec 31, 2023 0.27